These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
29. Current neurosurgical management and the impact of the extent of resection in the treatment of malignant gliomas of childhood: a report of the Children's Cancer Group trial no. CCG-945. Wisoff JH; Boyett JM; Berger MS; Brant C; Li H; Yates AJ; McGuire-Cullen P; Turski PA; Sutton LN; Allen JC; Packer RJ; Finlay JL J Neurosurg; 1998 Jul; 89(1):52-9. PubMed ID: 9647172 [TBL] [Abstract][Full Text] [Related]
31. Comparison of postoperative radiotherapy and combined postoperative radiotherapy and chemotherapy in the multidisciplinary management of malignant gliomas. A joint Radiation Therapy Oncology Group and Eastern Cooperative Oncology Group study. Chang CH; Horton J; Schoenfeld D; Salazer O; Perez-Tamayo R; Kramer S; Weinstein A; Nelson JS; Tsukada Y Cancer; 1983 Sep; 52(6):997-1007. PubMed ID: 6349785 [TBL] [Abstract][Full Text] [Related]
32. Controversies in the treatment of low-grade astrocytomas and oligodendrogliomas. Levin VA Curr Opin Oncol; 1996 May; 8(3):175-7. PubMed ID: 8804814 [TBL] [Abstract][Full Text] [Related]
33. [Results of conventional radiotherapy in malignant gliomas:]. Shibamoto Y; Yamashita J; Takahashi M; Yamasaki T; Kikuchi H; Abe M Gan No Rinsho; 1989 Sep; 35(11):1240-6. PubMed ID: 2554004 [TBL] [Abstract][Full Text] [Related]
34. Low-grade astrocytomas: the prognostic value of fibrillary, gemistocytic, and protoplasmic tumor histology. Babu R; Bagley JH; Park JG; Friedman AH; Adamson C J Neurosurg; 2013 Aug; 119(2):434-41. PubMed ID: 23662821 [TBL] [Abstract][Full Text] [Related]
36. Intra-operative characterization of gliomas by near-infrared spectroscopy: possible association with prognosis. Asgari S; Röhrborn HJ; Engelhorn T; Stolke D Acta Neurochir (Wien); 2003 Jun; 145(6):453-59; discussion 459-60. PubMed ID: 12836069 [TBL] [Abstract][Full Text] [Related]
37. Cells with TP53 mutations in low grade astrocytic tumors evolve clonally to malignancy and are an unfavorable prognostic factor. Ishii N; Tada M; Hamou MF; Janzer RC; Meagher-Villemure K; Wiestler OD; Tribolet N; Van Meir EG Oncogene; 1999 Oct; 18(43):5870-8. PubMed ID: 10557074 [TBL] [Abstract][Full Text] [Related]
38. Intrinsic radiation sensitivity may not be the major determinant of the poor clinical outcome of glioblastoma multiforme. Taghian A; Ramsay J; Allalunis-Turner J; Budach W; Gioioso D; Pardo F; Okunieff P; Bleehen N; Urtasun R; Suit H Int J Radiat Oncol Biol Phys; 1993 Jan; 25(2):243-9. PubMed ID: 8380568 [TBL] [Abstract][Full Text] [Related]
39. Prognostic value of the expression of tumor suppressor genes p53, p21, p16 and prb, and Ki-67 labelling in high grade astrocytomas treated with radiotherapy. Kirla R; Salminen E; Huhtala S; Nuutinen J; Talve L; Haapasalo H; Kalimo H J Neurooncol; 2000; 46(1):71-80. PubMed ID: 10896207 [TBL] [Abstract][Full Text] [Related]
40. Prognostic value of flow cytometry and correlation to some conventional prognostic factors: a retrospective study of archival specimens of 134 astrocytomas. Vavruch L; Nordenskjöld B; Carstensen J; Eneström S J Neurosurg; 1996 Jul; 85(1):146-51. PubMed ID: 8683265 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]